| Literature DB >> 21951830 |
Nicola H Chapman1, Steven P Lazar, Margaret Fry, Marissa N Lassere, Beng H Chong.
Abstract
BACKGROUND: Venous Thromboembolism (VTE) is a cause of hospital mortality and managing its morbidity is associated with significant expenditure. Uptake of evidenced based guideline recommendations intended to prevent VTE in hospital settings is sub-optimal. This study was conducted to explore clinicians' attitudes and the clinical environment in which they work to understand their reluctance to adopt VTE prophylaxis guidelines.Entities:
Mesh:
Year: 2011 PMID: 21951830 PMCID: PMC3200175 DOI: 10.1186/1472-6963-11-240
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Questions used to direct discussion with doctors to collect information about their attitudes to VTE prophylaxis and the barriers and facilitators to them adopting VTE Clinical Practice Guidelines
| 1 | When you are presented with a patient with a particular problem how do you ensure the appropriate care is provided and no aspect of care is overlooked? |
|---|---|
| 2 | How are changes or new research findings incorporated into your practice? |
| 3 | Some people think there is some variability in the practice of medicine. Why do you think this perception exists? How is consistency of treatment ensured in your area? |
| 4 | In general what do you know and how do you feel about VTE prophylaxis? |
| 5 | What influences whether a patient is VTE risk assessed in your ward and who oversees the assessment? What is the process in different parts of the hospital for a patient receiving or not receiving VTE prophylaxis? What is your role? |
| 6 | How often do you check junior staff are doing what you assume should be done and what you have asked to be done? |
| 7 | Can you tell me about a particular patient on your ward that is now receiving |
| i. Anticoagulant prophylaxis? | |
| ii. Mechanical prophylaxis? | |
| iii. Not receiving either? | |
| 8 | What was it about that patient or their management that has resulted in them receiving or not receiving prophylaxis? |
| 9 | How have you gained your information and knowledge about VTE prophylaxis? |
| 10 | Do you know of anyone who has had poor outcomes because of VTE prophylaxis, or lack thereof? Has it changed your perspective? |
| 11 | How do you feel about the way this hospital manages/uses VTE prophylaxis in general? |
| 12 | In an ideal world where resources are not an issue how would you ensure VTE prophylaxis is optimized at this hospital? * |
| 13 | I will now give you the official guidelines that are endorsed by this hospital, please take a moment to review them. Are you familiar with them? * |
| 14 | Do you have any thoughts on them, on their improvement or otherwise. * |
* Questions added after completion of first 8 interviews.
Figure 1Data displaying medical and surgical specialties of clinicians interviewed (n = 40).
Demographic data for participants (n = 40)
| Characteristic | Value |
|---|---|
| Gender | |
| Female, n (%) | 23 (58%) |
| Age, mean (SD) | 33.3 (11.1) |
| Hospital, n (%) | |
| St. George Hospital | 34 (85%) |
| Prince of Wales Hospital | 6 (15%) |
| Clinical Specialty, n (%) | |
| Medical | 26 (65%) |
| Surgical | 14 (35%) |
| Position, n (%) | |
| Senior Clinician | 12 (30%) |
| Registrar | 8 (20%) |
| Resident Medical Officer/Intern | 20 (50%) |
| Years in current position, mean (SD) | 5.4 (7.6) |
Abbreviations: SD, Standard Deviation